TY - JOUR
T1 - miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis
AU - Hermann, Helen
AU - Runnel, Toomas
AU - Aab, Alar
AU - Baurecht, Hansjörg
AU - Rodriguez, Elke
AU - Magilnick, Nathaniel
AU - Urgard, Egon
AU - Šahmatova, Liisi
AU - Prans, Ele
AU - Maslovskaja, Julia
AU - Abram, Kristi
AU - Karelson, Maire
AU - Kaldvee, Bret
AU - Reemann, Paula
AU - Haljasorg, Uku
AU - Rückert, Beate
AU - Wawrzyniak, Paulina
AU - Weichenthal, Michael
AU - Mrowietz, Ulrich
AU - Franke, Andre
AU - Gieger, Christian
AU - Barker, Jonathan
AU - Trembath, Richard
AU - Tsoi, Lam C.
AU - Elder, James T.
AU - Tkaczyk, Eric R.
AU - Kisand, Kai
AU - Peterson, Pärt
AU - Kingo, Külli
AU - Boldin, Mark
AU - Weidinger, Stephan
AU - Akdis, Cezmi A.
AU - Rebane, Ana
N1 - Funding Information:
This work was supported by European Regional Fund with Archimedes Foundation, EU structural assistance grant SARMP12219T, Estonian Ministry of Education and Research grant REMARK (SARBS12096T), European Union through the European Regional Development Fund (Project No. 2014-2020.4.01.15-0012), institutional research grant IUT2-2 and personal research grants PUT214, PUT177, PUT1669, and PUT1465 from Estonian Research Council, Swiss National Science Foundation grants 320030-140772 and 31-30-156823 and the Christine Kühne-Center for Allergy Research and Education, Davos Switzerland (CK-CARE). This study makes use of genome-wide analysis data generated by the Wellcome Trust Case-Control Consortium (WTCCC). A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk . Funding for the WTCCC was provided by the Wellcome Trust under award 076113 and 085475. The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum München—German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universität, as part of LMUinnovativ. The project received infrastructure support through the DFG Clusters of Excellence “Inflammation at Interfaces” (grants EXC306 and EXC306/2), and was by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (sysINFLAME, grant # 01ZX1306A). Support for the case-control psoriasis sample used for this study was provided by the National Institutes of Health (R01AR042742, R01AR050511, R01AR054966, R01AR062382, R01AR065183 to JTE). JTE is supported by the Ann Arbor Veterans Affairs Hospital.
Publisher Copyright:
© 2017 The Authors
PY - 2017
Y1 - 2017
N2 - miR-146a inhibits inflammatory responses in human keratinocytes and in different mouse models of skin inflammation. Little is known about the role of miR-146b in the skin. In this study, we confirmed the increased expression of miR-146a and miR-146b (miR-146a/b) in the lesional skin of patients with psoriasis. The expression of miR-146a was approximately twofold higher than that of miR-146b in healthy human skin, and it was more strongly induced by stimulation of proinflammatory cytokines in keratinocytes and fibroblasts. miR-146a/b target genes regulating inflammatory responses or proliferation were altered in the skin of patients with psoriasis, among which FERMT1 was verified as a direct target of miR-146a. In silico analysis of genome-wide data from >4,000 psoriasis cases and >8,000 controls confirmed a moderate association between psoriasis and genetic variants in the miR-146a encoding gene. Transfection of miR-146a/b suppressed and inhibition enhanced keratinocyte proliferation and the expression of psoriasis-related target genes. Enhanced expression of miR-146a/b-influenced genes was detected in cultured keratinocytes from miR-146a−/− and skin fibroblasts from miR-146a−/− and miR-146b−/− mice stimulated with psoriasis-associated cytokines as compared with wild-type mice. Our results indicate that besides miR-146a, miR-146b is expressed and might be capable of modulation of inflammatory responses and keratinocyte proliferation in psoriatic skin.
AB - miR-146a inhibits inflammatory responses in human keratinocytes and in different mouse models of skin inflammation. Little is known about the role of miR-146b in the skin. In this study, we confirmed the increased expression of miR-146a and miR-146b (miR-146a/b) in the lesional skin of patients with psoriasis. The expression of miR-146a was approximately twofold higher than that of miR-146b in healthy human skin, and it was more strongly induced by stimulation of proinflammatory cytokines in keratinocytes and fibroblasts. miR-146a/b target genes regulating inflammatory responses or proliferation were altered in the skin of patients with psoriasis, among which FERMT1 was verified as a direct target of miR-146a. In silico analysis of genome-wide data from >4,000 psoriasis cases and >8,000 controls confirmed a moderate association between psoriasis and genetic variants in the miR-146a encoding gene. Transfection of miR-146a/b suppressed and inhibition enhanced keratinocyte proliferation and the expression of psoriasis-related target genes. Enhanced expression of miR-146a/b-influenced genes was detected in cultured keratinocytes from miR-146a−/− and skin fibroblasts from miR-146a−/− and miR-146b−/− mice stimulated with psoriasis-associated cytokines as compared with wild-type mice. Our results indicate that besides miR-146a, miR-146b is expressed and might be capable of modulation of inflammatory responses and keratinocyte proliferation in psoriatic skin.
U2 - 10.1016/j.jid.2017.05.012
DO - 10.1016/j.jid.2017.05.012
M3 - Journal article
C2 - 28595995
AN - SCOPUS:85028313546
SN - 0022-202X
VL - 137
SP - 1945
EP - 1954
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 9
ER -